Ultrasound of the liver

Radiologic Clinics of North America

Volumn 43, Issue 5 SPEC. ISS., 2005, Pages 815-826

  Kono, Yuko ^a   Mattrey, Robert F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AF 0150; ALBUNEX; BR 1; BR 14; CONTRAST MEDIUM; ECHOVIST; FS 069; GADOLINIUM; IODINATED POPPYSEED OIL; NC 100100; PERFLEXANE; PERFLUTREN; SHU 508; SONOVUE;

CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HIGH RISK POPULATION; HUMAN; IMAGING SYSTEM; LIVER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; PRIORITY JOURNAL; REVIEW; ULTRASOUND;

EID: 23744501508     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2005.05.007     Document Type: Review

References (38)

1. B. Daniele, A. Bencivenga, and A.S. Megna Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma Gastroenterology 127 2004 S108 S112
2. R. Gramiak, and P.M. Shah Echocardiography of the aortic root Invest Radiol 3 1968 356 366
3. R.F. Mattrey, F.W. Scheible, and B.B. Gosink Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material Radiology 145 1982 759 762
4. K.J. Parker, T.A. Tuthill, and R.M. Lerner A particulate contrast agent with potential for ultrasound imaging of liver Ultrasound Med Biol 13 1987 555 566
5. R.F. Mattrey, G. Strich, and R.E. Shelton Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results Radiology 163 1987 339 343
6. R.F. Mattrey, G. Steinbach, and Y. Lee High-resolution harmonic gray-scale imaging of normal and abnormal vessels and tissues in animals Acad Radiol 5 Suppl 1 1998 S63 S65 [discussion: S64-72]
7. A.P. Miller, and N.C. Nanda Contrast echocardiography: new agents Ultrasound Med Biol 30 2004 425 434
8. S.R. Wilson, and P.N. Burns Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging Semin Liver Dis 21 2001 147 159
9. E. Quaia, F. Stacul, and M. Bertolotto Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent Acad Radiol 9 Suppl 2 2002 S376 S379
10. D. Strobel, S. Raeker, and P. Martus Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions Int J Colorectal Dis 18 2003 63 72
11. Y. Kono, G.C. Steinbach, and T. Peterson Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats Radiology 224 2002 253 257
12. T. Albrecht, M.J. Blomley, and D.O. Cosgrove Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent Lancet 353 1999 1579 1583
13. P.N. Burns Instrumentation for contrast echocardiography Echocardiography 19 2002 241 258
14. C.B. Sirlin, M.S. Girard, and K.G. Baker Effect of acquisition rate on liver and portal vein enhancement with microbubble contrast Ultrasound Med Biol 25 1999 331 338
15. S.R. Wilson, P.N. Burns, and D. Muradali Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis Radiology 215 2000 153 161
16. T.H. Bryant, M.J. Blomley, and T. Albrecht Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study Radiology 232 2004 799 809
17. E. Quaia, F. Calliada, and M. Bertolotto Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence Radiology 232 2004 420 430
18. P.C. Freeny, and W.M. Marks Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT Radiology 160 1986 613 618
19. H. Honda, Y. Matsuura, and H. Onitsuka Differential diagnosis of hepatic tumors (hepatoma, hemangioma, and metastasis) with CT: value of two-phase incremental imaging AJR Am J Roentgenol 159 1992 735 740
20. S.P. Quillin, S. Atilla, and J.J. Brown Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions Magn Reson Imaging 15 1997 275 285
21. C.B. Sirlin, Y.Z. Lee, and M.S. Girard Contrast-enhanced B-mode US angiography in the assessment of experimental in vivo and in vitro atherosclerotic disease Acad Radiol 8 2001 162 172
22. S.K. Kim, H.K. Lim, and Y.H. Kim Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings Radiographics 23 2003 107 121
23. K. Kubota, N. Hisa, and T. Nishikawa Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI Abdom Imaging 26 2001 184 190
24. S. Sumi, Y. Yamashita, and K. Mitsuzaki Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma AJR Am J Roentgenol 172 1999 67 71
25. T. Hosoki, Y. Yosioka, and T. Matsubara Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization: assessment of the therapeutic effect Acta Radiol 40 1999 639 643
26. M. De Santis, S. Alborino, and P.L. Tartoni Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization Eur Radiol 7 1997 10 16
27. B.S. Kuszyk, J.K. Boitnott, and M.A. Choti Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model Radiology 217 2000 477 486
28. D. Cioni, R. Lencioni, and C. Bartolozzi Percutaneous ablation of liver malignancies: imaging evaluation of treatment response Eur J Ultrasound 13 2001 73 93
29. H. Ding, M. Kudo, and H. Onda Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT Radiology 221 2001 721 730
30. L. Solbiati, T. Ierace, and M. Tonolini Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound Eur J Radiol 51 2004 S19 S23
31. Kono Y., Alton K., Rose S., et al. Early assessment of treatment success with contrast-enhanced ultrasound post transarterial chemoembolization for hepatocellular carcinoma [abstract 385]. Radiological Society of North America 90th Scientific Assembly and Annual Meeting. Chicago, Illinois, November 27-December 2, 2004
32. A.L. Klibanov, P.T. Rasche, and M.S. Hughes Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles Invest Radiol 39 2004 187 195
33. W.J. Zwiebel Sonographic diagnosis of hepatic vascular disorders Semin Ultrasound CT MR 16 1995 34 48
34. J.B. Kruskal, P.A. Newman, and L.G. Sammons Optimizing Doppler and color flow US: application to hepatic sonography Radiographics 24 2004 657 675
35. P.N. Burns, J.E. Powers, and T. Fritzsch Harmonic imaging: new imaging and Doppler method for contrast-enhanced ultrasound Radiology 185 P 1992 142
36. Y. Kono, R. Mattrey, and S. Pinnell Ultrasound contrast venography of TIPS: gray-scale ultrasound vs. x-ray venography J Ultrasound Med 20 3 2001 S82
37. M.J.K. Blomley, A.K.P. Lim, and C.J. Harvey Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study Gut 52 2003 1188 1193
38. H. Kitamura, S. Kawasaki, and K. Nakajima Correlation between microbubble contrast-enhanced color Doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results J Clin Ultrasound 30 2002 465 471